Background:
Nosocomial infections increase mortality rate in neonates. Studies have attributed the use of H2 blockers as one of the various factors that increase the risk of nosocomial infections.
Archives of Pediatric Infectious Diseases
Nosocomial infections increase mortality rate in neonates. Studies have attributed the use of H2 blockers as one of the various factors that increase the risk of nosocomial infections.
To define the relationship between nosocomial infection and Ranitidine in very low birth weight (VLBW) infants admitted in the NICU of a tertiary care hospital.
All VLBW infants admitted during the study period of 3 years from April 2008 to March 2011 were included. All relevant pre-and peri-natal data including all administered medications was collected from the case notes and documented on a pre-designed questionnaire. Rate of nosocomial infection (NI) had been compared between patients who were administered Ranitidine and those who did not receive this medication.
During the study period, 564 VLBW infants were admitted in the NICU; 157, (27.8%) contracted nosocomial infections, 130 (82.8%) developed pneumonia, 21, (13.4%) had sepsis with positive blood cultures and 6 infants (1.1%) developed necrotizing enterocolitis. Factors remaining independently significant for development of NI after adjustment were as follows: RDS (P = 0.001. OR = 3.29; 95%CI = 1.646.6); CLD (P < 0.001. OR = 3.83; 95%CI = 2.067.11); anemia (P = 0.005. OR = 1.96; 95% CI = 1.23-3.13); use of Ibuprofen (P = 0.03. OR = 1.99; 95%CI = 1.06-3.74), and treatment with Ranitidine (P = 0.009, OR = 1.92, 95%CI = 1.18-3.12).
Use of Ranitidine was associated with a significantly increased risk of nosocomial infections in VLBW infant.
© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Afjeh S, Sabzehei M, Fallahi M, Esmaili F. Outcome of Very Low Birth Weight Infants Over 3 Years Report From an Iranian Center. Inn J Pediatr. 2013;23(5):. doi:
Afjeh S, Sabzehei M, Fahimzad S, Shiva F, Shamshiri A, et al. Antibiotic Therapy for Very Low Birth Weigh Newborns in NICU. Inn J Pediatr. 2016;26(2):e2612. doi: https://doi.org/10.5812/ijp.2612
Noori Sanami M, Radfar M, Shirvani F, Nabavi M, Gachkar L. Candida Colonization in Low Birth Weight and Very Low Birth Weight Infants in a Neonatal Intensive Care Unit. Arch Pediatr Infect Dis. 2015;3(4):e21234. doi: https://doi.org/10.5812/pedinfect.21234
Atalay D, Salihoğlu &, Can E, Beşkardeş A, Hatipoğlu S. Short-Term Outcomes of Very Low Birth Weight Infants Born at a Tertiary Care Hospital, Istanbul, Turkey. Inn J Pediatr. 2013;23(2):. doi:
Hoseini M, Alipour A, Vazirian S, Hemati M, Hashemian A. Nosocomial bloodstream infection and its risk factors in Razi Hospital’s Neonatal intensives care unit of Kermanshah (2002). J Kermanshah Univ Med Sci. 2003;7(3):e81262. doi:
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):